In vitro and in vivo enhancement of ddI activity against Rauscher murine leukemia virus by ribavirin
- 30 June 1995
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 27 (3) , 317-323
- https://doi.org/10.1016/0166-3542(95)00018-h
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- An ELISA system for evaluating antiretroviral activity against Rauscher murine leukemia virusAntiviral Research, 1992
- Modulation of Metabolism and Anti-HIV-1 Activity of Purine 2′,3′-Dideoxynucleosides by IMP Dehydrogenase InhibitorsPublished by Springer Nature ,1991
- A three-dimensional model to analyze drug-drug interactionsAntiviral Research, 1990
- Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitroAntimicrobial Agents and Chemotherapy, 1987
- Evaluation of the anti-herpesvirus drug combinations: Virazole plus arabinofuranosylhypoxanthine and Virazole plus arabinofuranosyladenineAntiviral Research, 1982
- Inhibition of Gross Leukemia Virus-Induced Plaque Formation in XC Cells by 3-Deazauridine2JNCI Journal of the National Cancer Institute, 1974
- Plaque assay techniques for murine leukemia virusesVirology, 1970